과제정보
This work was supported by the National Research Foundation of Korea (NRF) grant funded by the Korea government (MSIT) (No. 2021R1A2C1012058).
참고문헌
- Campbell WC, Fisher MH, Stapley EO, Albers-Schonberg G, Jacob TA. Ivermectin: a potent new antiparasitic agent. Science 1983; 221: 823-828. https://doi.org/10.1126/science.6308762
- Duangkaew L, Larsuprom L, Anukkul P, Lekcharoensuk C, Chen C. A field trial in Thailand of the efficacy of oral fluralaner for the treatment of dogs with generalized demodicosis. Vet Dermatol 2018; 29: 208-e74.
- Ferrer L. Demodicosis: treatment of difficult and desperate cases. In: Proceedings of the Continuing Education Program Practical, Advanced, Equine, Feline, Exotic Pets. 2016: 108-111.
- Fourie JJ, Liebenberg JE, Horak IG, Taenzler J, Heckeroth AR, Frenais R. Efficacy of orally administered fluralaner (BravectoTM) or topically applied imidacloprid/moxidectin (Advocate®) against generalized demodicosis in dogs. Parasit Vectors 2015; 8: 187. https://doi.org/10.1186/s13071-015-0775-8
- Gassel M, Wolf C, Noack S, Williams H, Ilg T. The novel isoxazoline ectoparasiticide fluralaner: selective inhibition of arthropod γ-aminobutyric acid- and L-glutamate-gated chloride channels and insecticidal/acaricidal activity. Insect Biochem Mol Biol 2014; 45: 111-124. https://doi.org/10.1016/j.ibmb.2013.11.009
- Hensel P, Santoro D, Favrot C, Hill P, Griffin C. Canine atopic dermatitis: detailed guidelines for diagnosis and allergen identification. BMC Vet Res 2015; 11: 196. https://doi.org/10.1186/s12917-015-0515-5
- Johnstone IP. Doramectin as a treatment for canine and feline demodicosis. Aust Vet Pract 2002; 32: 98-103.
- Koch SN. Updates on the management of canine demodicosis. TVP Journal 2017; 2017: 77-85.
- Mueller RS. Treatment protocols for demodicosis: an evidence-based review. Vet Dermatol 2004; 15: 75-89. https://doi.org/10.1111/j.1365-3164.2004.00344.x
- Mueller RS, Rosenkrantz W, Bensignor E, Karas-Tecza J, Paterson T, Shipstone MA. Diagnosis and treatment of demodicosis in dogs and cats: clinical consensus guidelines of the World Association for Veterinary Dermatology. Vet Dermatol 2020; 31: 5-27. https://doi.org/10.1111/vde.12906
- Noli C, Auxilia ST. Treatment of canine Old World visceral leishmaniasis: a systematic review. Vet Dermatol 2005; 16: 213-232. https://doi.org/10.1111/j.1365-3164.2005.00460.x
- Rohdich N, Roepke RK, Zschiesche E. A randomized, blinded, controlled and multi-centered field study comparing the efficacy and safety of BravectoTM (fluralaner) against FrontlineTM (fipronil) in flea- and tick-infested dogs. Parasit Vectors 2014; 7: 83. https://doi.org/10.1186/1756-3305-7-83
- Sainz A, Roura X, Miro G, Estrada-Pena A, Kohn B, Harrus S, et al. Guideline for veterinary practitioners on canine ehrlichiosis and anaplasmosis in Europe. Parasit Vectors 2015; 8: 75. https://doi.org/10.1186/s13071-015-0649-0
- Scott DW, Miller WH, Griffin CE. Parasitic skin disease. In: Miller WH, Griffin CE and Campbell KL, editors. Muller and Kirk's small animal dermatology. 7th ed. Philadelphia: Saunders. 2013: 423-516.
- Solano-Gallego L, Sainz A, Roura X, Estrada-Pena A, Miro G. A review of canine babesiosis: the European perspective. Parasit Vectors 2016; 9: 336. https://doi.org/10.1186/s13071-016-1596-0
- Wagner R, Wendlberger U. Field efficacy of moxidectin in dogs and rabbits naturally infested with Sarcoptes spp., Demodex spp. and Psoroptes spp. mites. Vet Parasitol 2000; 93: 149-158. https://doi.org/10.1016/S0304-4017(00)00357-5
- Walther FM, Allan MJ, Roepke RK, Nuernberger MC. Safety of fluralaner chewable tablets (BravectoTM), a novel systemic antiparasitic drug, in dogs after oral administration. Parasit Vectors 2014; 7: 87. https://doi.org/10.1186/1756-3305-7-87